Pathstone Family Office’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
FP
HCM
PCMC
WCG
Pathstone Family Office's CELG Position: Q4 2019 in Review
Pathstone Family Office sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,000 shares — an estimated $99K sold.
Pathstone Family Office first reported a position in CELG in Q3 2014 and held it in 15 quarters. The position peaked at $145K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Pathstone Family Office reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Pathstone Family Office sold 1,000 Celgene Corp shares in Q4 2019, an estimated $99K.
- Pathstone Family Office first reported a position in Celgene Corp in Q3 2014 and held it in 15 quarters.
- Pathstone Family Office's Celgene Corp position peaked at $145K in Q1 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Pathstone Family Office's 13F filing for Q4 2019, filed 14 Feb 2020.